Table 1 Correlation of ACSL4 expression with clinicopathologic parameters

Age

 71.4 years (range:33–89 years)

71.8

69

0.292

Sex

0.901

(0.271–2.990)

0.864

 Male

57

49

8

 Female

39

34

5

Location

1.351

(0.408–4.476)

0.622

 Pbt

43

38

5

 Ph

53

45

8

Histology

2.836

(0.489–16.439)

0.227

 Well ~ mod

90

78

11

 Por

6

5

2

Size

 25.2 (1–80 mm)

25

26.5

0.663

pT

1.459

(0.169–12.581)

0.729

 T1

10

9

1

 ≧T2

86

74

12

LN metastasis

0.967

(0.299–3.124)

0.744

 Negative

51

43

8

 Positive

45

39

6

Lymphatic invasion

1.213

(1.092–1.348)

0.034

 Negative

21

22

0

 Positive

75

61

13

Vascular invasion

9.191

(1.142–73.991)

0.014

 Negative

39

36

1

 Positive

57

47

12

Neuro invasion

5.474

(0.676–44.346)

0.078

 Negative

27

26

1

 Positive

69

57

12

Margin

1.775

(0.426–7.402)

0.426

 Negative

81

71

10

 Positive

15

12

3

Neoadjuvant chemotherapy

0.622

(0.158–2.447)

0.494

 No

66

56

10

 Yes

30

27

3

Adjuvant chemotherapy

1.202

(0.303–4.775)

0.793

 No

25

22

3

 Yes

71

61

10

CA19-9

0.894

(0.276–2.890)

0.851

 <37

42

36

6

 ≧37

54

47

7

Recurrence

5.116

(1.068–24.517)

0.027

 Absent

43

40

2

 Present

53

43

11